Literature DB >> 15552612

Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of Leser-Trelat.

Timothy Patton1, Matthew Zirwas, Nancy Nieland-Fisher, Drazen Jukic.   

Abstract

Cytarabine, used for the treatment of acute myelogenous leukemia, can cause a rare reaction of inflammation of existing seborrheic keratoses. We report a case of cytarabine induced inflammation of seborrheic keratoses mimicking a vesicular eruption in 53-year-old man with acute myelogenous leukemia.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15552612

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN： 1545-9616            Impact factor:   2.114


  3 in total

Review 1.  Recent advances in managing and understanding seborrheic keratosis.

Authors:  Uwe Wollina
Journal:  F1000Res       Date:  2019-08-28

2.  Eruptive Seborrheic Keratoses Are Associated With a Co-Occurring Malignancy in the Majority of Reported Cases: A Systematic Review.

Authors:  Sara Mirali; Asfandyar Mufti; Rafael Paolo Lansang; Muskaan Sachdeva; Jensen Yeung
Journal:  J Cutan Med Surg       Date:  2021-11-28       Impact factor: 2.092

3.  "Pseudo" Nomenclature in Dermatology: What's in a Name?

Authors:  Sangita Ghosh; Vijay Kumar Jain
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.